Anthropic appointed Ben Bernanke, the Federal Reserve chair from 2006 to 2014, to its Long-Term Benefit Trust, the outside body that advises the company and selects its board members. He becomes the trust’s fourth member. The appointment puts a central banker best known for managing the 2008 financial crisis inside the governance layer of a company racing toward a possible IPO at a $965 billion valuation.
The Long-Term Benefit Trust is Anthropic’s answer to a problem most AI labs have not solved: who checks the company when commercial pressure and safety commitments pull in different directions. Trustees hold no equity in Anthropic and are compensated only for their time, according to the company. They also pick their own successors in consultation with Anthropic, a structure meant to insulate the trust from investor influence.
Bernanke’s resume is built for exactly the kind of stress test AI’s economic disruption could bring. He took over the Fed from Alan Greenspan and, within two years, was steering monetary policy through the worst downturn since the Great Depression. His response, pushing rates to zero and launching large-scale asset purchases, became the template regulators reached for again during later shocks. He later worked at the Brookings Institution, Citadel and Pimco, and won the 2022 Nobel Prize in economics for research explaining the causes of the Great Depression.
“Anthropic has created a unique governance structure to try to ensure that the long-run benefits of AI for humanity far outweigh the risks,” Bernanke said in a statement. “I am honored to have this opportunity, and I will try to contribute in any way I can to this critical mission.”
The timing points to a specific concern. Anthropic’s own leadership has spent the past year warning publicly that AI could displace large categories of white-collar work faster than labor markets can absorb the shock. A former Fed chair is the person best positioned inside a governance body to translate that warning into something more concrete than a talking point: a read on how fast AI adoption could show up in employment data, wage growth, and productivity statistics the Fed itself tracks.
Bernanke joins Neil Buddy Shah, chief executive of the Clinton Health Access Initiative, national security expert Richard Fontaine, and international affairs expert Mariano-Florentino Cuellar, who was appointed in January, CNBC reported. The trust’s stated power, appointing Anthropic’s board, is real on paper. What is untested is whether it has ever been exercised against the wishes of Anthropic’s executives or major investors, since the structure has not faced a public conflict since the company’s 2021 founding by researchers and executives who left OpenAI.
That gap matters more as Anthropic approaches a public listing. An IPO, which CNBC reported the company is preparing for and which could happen as soon as this year, invites shareholders whose incentives run toward growth and revenue, not the trust’s mandate to weigh long-run societal benefit against near-term risk. A trust stacked with credentialed outsiders who hold no equity is a governance signal to regulators and the public. It is not yet evidence that the trust will override a board or a CEO when the two disagree.
For operators and investors tracking Anthropic ahead of any listing, the question worth monitoring is not who sits on the trust but whether it ever blocks a board appointment or a strategic decision once real money is on the table. Bernanke’s presence raises the credibility of that check. It does not yet prove the check works.
This article is based on reporting by CNBC, published July 9, 2026.
